October 12, 2007 - CompareNetworks Media Group launched its new Acuity Medical Education program Oct. 11 to aid in doctors’ continuing education.

The company says Acuity Medical Education will provide the highest standards of science and quality instruction by working with the industry’s top thought leaders to design programs for live, multimedia and print education, allowing medical professionals to fulfill their continuing education.

October 12, 2007 - Angiotech Pharmaceuticals Inc. said Oct. 11 it received CE Mark approval to begin marketing the Quill Self-Retaining System (SRS) MONODERM sutures in Europe.

This CE Mark approval follows Angiotech’s August clearance from the FDA to begin marketing the Quill SRS MONODERM product line in the United States.

October 12, 2007 - Langford IC Systems Inc. today introduced the Manzi Mach 1 Cleaner-Processor, a parametric release liquid chemical instrument processor that cleans, sterilizes and rinses instruments at the point of use.

The system is designed for use by hospitals, medical clinics, and in any medical setting conducting procedures involving medical instruments.

The Manzi system cleans and reprocesses instruments, at the point of use, using no connectors. The uninterrupted, three-step process takes place in a single chamber as follows:


The ability to evaluate the efficacy of a given treatment for cancer is critical in achieving the best prognosis and care for patients. However, most standard methods of treatment response evaluation rely on visualizing a change in tumor size, which often occurs months after treatment begins.

The objective of ASTRO’s 49th Annual Meeting is “Treating Cancer While Preserving Quality of Life.” With radiation therapy, in particular, achieving this goal requires accuracy and a bit of finesse to precisely deliver treatment with minimal collateral damage. Consider it a skillful fusion of art and science.


Until recently, certain types of cancer patients had very few or no options after they had been turned down as candidates for traditional surgery. Surgeons may reach the conclusion that surgery will not be effective for a patient if a tumor is in an unreachable anatomical location or the patient’s medical history includes special concerns.
SBRT changes the prognosis

Fighting cancer is serious business. Every day in hospitals and cancer clinics worldwide, radiation oncologists, neurosurgeons and physicists combat the disease in its myriad forms with the help of medicine’s most sophisticated tools and technologies. As radiation therapy continues to evolve, the latest cancer treatments are not only becoming more precise, but also more widely available.
As little as 10 years ago, for example, intensity-modulated radiation therapy (IMRT) was only offered at a few university hospitals; today, virtually every radiation center has IMRT.

Fighting cancer is a tough-enough ordeal for patients and clinicians alike. But waging war against an eminently deadly organic mass with the right tools that pinpoint the delivery of radiation therapy without harming healthy surrounding tissue in a reimbursement-challenged healthcare environment ultimately fuses art with science.

October 12, 2007 - Scientists at Oxford University have released the latest version of their FSL software, which reportedly allows clinicians and researchers to analyze images of the brain, providing insights and improved treatment of conditions including schizophrenia, Alzheimer’s disease, multiple sclerosis, epilepsy and Parkinson’s.

GE Healthcare released the latest version of Centricity Enterprise, an integrated software suite of clinical and financial applications that is designed to improve patient care and increase collaboration between clinicians, reportedly providing a better overall healthcare environment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now